AEOLUS PHARMACEUTICALS, INC. (AOLS) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 172 transactions totaling $13.1M, demonstrating a bullish sentiment with $6.9M in net insider flow. The most recent transaction on Dec 28, 2016 involved a transaction of 25,000 shares valued at $3.8K.
No significant insider buying has been recorded for AOLS in the recent period.
No significant insider selling has been recorded for AOLS in the recent period.
Based on recent SEC filings, insider sentiment for AOLS is bullish with an Insider Alignment Score of 76/100 and a net flow of $6.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AEOLUS PHARMACEUTICALS, INC. (AOLS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AOLS stock, having executed 172 transactions in the past 90 days. The most active insider is Opportunity Partners, Llc Xmark (Executive), who has made 56 transactions totaling $8.2M.
Get notified when executives and directors at AOLS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 28, 2016 | L. Mcmanus John | Executive | Award | 25,000 | $0.15 | $3.8K | |
| Mar 6, 2013 | L. Mcmanus John | Executive | Purchase | 10,000 | $0.35 | $3.5K | |
| Feb 19, 2013 | J. Krivulka Joseph | Executive | Purchase | 400,000 | $N/A | $0 | |
| Feb 19, 2013 | Partners, Llc Xmark Opportunity | Executive | Exercise | 59,149,999 | $N/A | $0 | |
| Feb 19, 2013 | Partners, Llc Xmark Opportunity | Executive | Sale | 1,793,894 | $0.33 | $592.0K | Large |
| May 23, 2012 | Skibsted Russell | Executive | Purchase | 7,027 | $0.24 | $1.7K | |
| Apr 5, 2012 | J. Krivulka Joseph | Executive | Purchase | 333,333 | $0.30 | $100.0K | |
| May 24, 2011 | L. Mcmanus John | Executive | Purchase | 300 | $0.47 | $141 | |
| May 24, 2011 | L. Mcmanus John | Executive | Purchase | 10,000 | $0.45 | $4.5K | |
| May 18, 2011 | Skibsted Russell | Executive | Purchase | 5,000 | $0.41 | $2.0K | |
| May 18, 2011 | Skibsted Russell | Executive | Purchase | 5,000 | $0.42 | $2.1K | |
| May 18, 2011 | Skibsted Russell | Executive | Purchase | 10,000 | $0.43 | $4.3K | |
| May 18, 2011 | L. Mcmanus John | Executive | Purchase | 10,000 | $0.43 | $4.3K | |
| May 18, 2011 | L. Mcmanus John | Executive | Purchase | 10,000 | $0.43 | $4.3K | |
| Mar 16, 2011 | Ltd. Efficacy Capital, | Executive | Sale | 3,799,380 | $0.61 | $2.3M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 118 | $10.0M | 53.6% |
Other(J) | 12 | $3.4M | 18.2% |
Sale(S) | 7 | $3.1M | 16.7% |
Conversion(C) | 4 | $2.0M | 10.7% |
Exercise(M) | 6 | $104.2K | 0.6% |
Small Acquisition(L) | 21 | $48.1K | 0.3% |
Award(A) | 1 | $3.8K | 0.0% |
Exercise (Options)(X) | 3 | $0 | 0.0% |
Insiders at AEOLUS PHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 9 insiders making 172 transactions totaling $10.0M in purchases versus $3.1M in sales, the net buying activity of $6.9M signals strong executive confidence. Opportunity Partners, Llc Xmark (Executive) leads the buying activity with $8.2M in transactions across all time.